Events & Resources

Learning Center
Read through guides, explore resource hubs, and sample our coverage.
Learn More
Events
Register for an upcoming webinar and track which industry events our analysts attend.
Learn More
Podcasts
Listen to our podcast, Behind the Numbers for the latest news and insights.
Learn More

About

Our Story
Learn more about our mission and how EMARKETER came to be.
Learn More
Our Clients
Key decision-makers share why they find EMARKETER so critical.
Learn More
Our People
Take a look into our corporate culture and view our open roles.
Join the Team
Our Methodology
Rigorous proprietary data vetting strips biases and produces superior insights.
Learn More
Newsroom
See our latest press releases, news articles or download our press kit.
Learn More
Contact Us
Speak to a member of our team to learn more about EMARKETER.
Contact Us
Already have a subscription?Sign In

Access All Charts and Data

Transparently sourced data in visual form, perfect for legitimizing your strategic ideas and thought leadership via internal and external presentations.

Access All Charts and Data

Transparently sourced data in visual form, perfect for legitimizing your strategic ideas and thought leadership via internal and external presentations.

Get a Demo
June 21, 2017

Most Exciting Opportunity for Their Company in 2020 According to Healthcare & Pharma Professionals Worldwide (% of respondents)

Note

Data was provided to eMarketer by Adobe.

Methodology

Data is from the June 2017 Econsultancy report titled "Digital Intelligence Briefing: 2017 Digital Trends in Healthcare and Pharma" in association with Adobe. 497 healthcare & pharma professionals worldwide were surveyed during November-December 2016. Respondents were from Africa (1%), Asia-Pacific (10%), Australia/New Zealand (8%), Europe (22%), the Middle East (1%), North America (57%) and other (1%). Respondents identified their roles as board-level (2%), C-level/general manager (2%), director/senior director (16%), junior executive/associate (18%), manager (35%), VP/SVP/EVP (2%) and other (25%).